SEARCH

SEARCH BY CITATION

References

  • Acs, G., Acs, P., Beckwith, S.M., Pitts, R.L., Clements, E., Wong, K. & Verma, A. (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Research, 61, 35613565.
  • Antonadou, D., Cardamakis, E., Puglisi, M., Malamos, N. & Throuvalas, N. (2001) Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies: final results of a randomized phase III study. European Journal of Cancer, 37(Suppl. 6), A530.
  • Bohlius, J., Langensiepen, S., Schwarzer, G., Seidenfeld, J., Piper, M., Bennet, C. & Engert, A. (2004) Erythropoietin for patients with malignant disease. Cochrane Database of Systematic Reviews, 3, CD003407.
  • Caro, J.J., Salas, M., Ward, A. & Goss, G. (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 22142221.
  • Cella, D., Lai, J.S., Chang, C.H., Peterman, A. & Slavin, M. (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer, 94, 528538.
  • Hedenus, M., Adriansson, M., San Miguel, J., Kramer, M.H., Schipperus, M.R., Juvonen, E., Taylor, K., Belch, A., Altes, A., Martinelli, G., Watson, D., Matcham, J., Rossi, G. & Littlewood, T.J. (2003) Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. British Journal of Haematology, 122, 394403.
  • Henke, M., Laszig, R., Rube, C., Schafer, U., Haase, K.D., Schilcher, B., Mose, S., Beer, K.T., Burger, U., Dougherty, C. & Frommhold, H. (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet, 362, 12551260.
  • Kaanders, J.H.A.M. & van der Kogel, A.J. (2004) Erythropoietin to treat anaemia in patients with head and neck cancer [Letter]. Lancet, 363, 7879.
  • Leyland-Jones, B. (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncology, 4, 459460.
  • Leyland-Jones, B. & Mahmud, S. (2004) Erythropoietin to treat anaemia in patients with head and neck cancer [Letter]. Lancet, 363, 80.
  • Littlewood, T.J., Bajetta, E., Nortier, J.W., Vercammen, E. & Rapoport, B. (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology, 19, 28652874.
  • Mittelman, M., Neumann, D., Peled, A., Kanter, P. & Haran-Ghera, N. (2001) Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proceedings of the National Academy of Sciences of the United States of America, 98, 51815186.
  • Olujohungbe, A., Handa, S. & Holmes, J. (1997) Does erythropoietin accelerate malignant transformation in multiple myeloma? Journal of Postgraduate Medicine, 73, 163164.
  • Österborg, A., Brandberg, Y., Molostova, V., Iosava, G., Abdulkadyrov, K., Hedenus, M. & Messinger, D. (2002) Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies. Journal of Clinical Oncology, 20, 24862494.
  • Ribatti, D., Vacca, A., Roccaro, A.M., Crivellato, E. & Presta, M. (2003) Erythropoietin as an angiogenic factor. European Journal of Clinical Investigation, 33, 891896.
  • Rosen, F.R., Haraf, D.J., Kies, M.S., Stenson, K., Portugal, L., List, M.A., Brockstein, B.E., Mittal, B.B., Rademaker, A.W., Witt, M.E., Pelzer, H., Weichselbaum, R.R. & Vokes, E.E. (2003) Multicenter randomized phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9, 16891697.
  • Stuben, G., Pottgen, C., Knuhmann, K., Schmidt, K., Stuschke, M., Thews, O. & Vaupel, P. (2003) Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. International Journal of Radiation Oncology, Biology, Physics, 55, 13581362.
  • Thews, O., Kelleher, D.K. & Vaupel, P. (2001) Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Research, 61, 13581361.
  • Vansteenkiste, J., Pirker, R., Massuti, B., Barata, F., Font, A., Fiegl, M., Siena, S., Gateley, J., Tomita, D., Colowick, A.B. & Musil, J. (2002) Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. Journal of the National Cancer Institute, 94, 12111220.
  • Yasuda, Y., Fujita, Y., Matsuo, T., Koinuma, S., Hara, S., Tazaki, A., Onozaki, M., Hashimoto, M., Musha, T., Ogawa, K., Fujita, H., Nakamura, Y., Shiozaki, H. & Utsumi, H. (2003) Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis, 24, 10211029.